Intra-Cellular Therapies to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Intra-Cellular Therapies (Nasdaq: ITCI) will present at the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 11:15 a.m. PT, according to a recent announcement. The presentation will be led by Sharon Mates, Ph.D., CEO and Chairman of the company. Interested attendees can access the live and archived webcast on the company's Investor Relations webpage. Intra-Cellular Therapies focuses on developing innovative treatments for central nervous system disorders, based on Nobel prize-winning research.

NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 41^st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. PT.

The live and archived webcast can be accessed under "Events & Presentations" in the Investor Relations section of the Company's website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.

About Intra-Cellular Therapies

Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.

Contact:

Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333

Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006

FAQ

When is Intra-Cellular Therapies scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference?

Intra-Cellular Therapies is scheduled to present on January 9, 2023, at 11:15 a.m. PT.

Who will be presenting for Intra-Cellular Therapies at the J.P. Morgan Healthcare Conference?

Sharon Mates, Ph.D., the CEO and Chairman, will be presenting.

How can I access the webcast of Intra-Cellular Therapies' presentation?

The webcast can be accessed under 'Events & Presentations' in the Investor Relations section of the company's website.

What does Intra-Cellular Therapies focus on developing?

The company focuses on therapeutics for central nervous system disorders.

What is the stock symbol for Intra-Cellular Therapies?

The stock symbol for Intra-Cellular Therapies is ITCI.